PROFUSA, INC.

PFSA ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2024
Revenue $100.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $1.6M
SG&A Expense $3.0M
Operating Income $-4.5M
Operating Margin -4,500.0%
Interest Expense
Pretax Income $-8.6M
Income Tax Expense $80.5K
Net Income $-9.2M
Net Margin -9,230.0%
EPS (Basic) $-357.14
EPS (Diluted) $-357.14
Shares Outstanding (Basic) 5.2M
Shares Outstanding (Diluted) 5.2M
Dividends Per Share